NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OptMed, Inc.

OptMed, Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.optmed.com/

Last Round

IPO

Jun 12, 2023

Total Funding Raised

$11.75M

Company Overview

OptMed, Inc. is a medical device company that develops and commercializes biocompatible polymer-based surgical adhesives and skin protectants for topical and internal clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

surgical adhesiveskin protectantwound closuremedical devicebiocompatible materialsmethylidene malonateMM212tissue adhesivesurgical gluewound managementFDA 510(k)ISO 13485topical adhesiveliquid bandage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OptMed, Inc. Comparables

Compare OptMed, Inc. with similar companies based on industry and business-model similarity.

OptMed, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chemence
79%
Advanced Medical Solutions Group
78%
H.B. Fuller Company
78%

OptMed, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOJun 12, 2023
Series BAug 1, 2017
Early FundingAug 11, 2015
Convertible DebtMar 17, 2015
AngelJun 27, 2014
Angel
Jun 11, 2013

OptMed, Inc. Investors

Notable investors and investment history

OptMed, Inc. investors
InvestorRounds
E.F. Hutton & Co.IPO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2017

    Raised $3M in Series B funding.

  • Mar 17, 2015

    $274K raised in a convertible debt round.

OptMed, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OptMed, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OptMed, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2007
Last FundingJun 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.